Dräger Medizintechnik GmbH (Lubeck, Germany) and Masimo
Corporation (Irvine, CA) announced a purchasing and licensing agreement under
which Dräger will integrate Masimo Signal Extraction pulse oximetry technology
into its future patient monitors which incorporate pulse oximetry.
Dräger
Medizintechnik GmbH is a leading manufacturer of medical equipment worldwide.
Dräger has earned a reputation of excellence in both product design and customer
support.
Masimo Signal Extraction pulse oximetry is the only technology
clinically proven accurate during patient motion and low perfusion. Numerous
published studies have shown a virtual elimination of false alarms without
sacrificing the ability to detect true alarms with Masimo Signal Extraction
pulse oximetry, as compared with the other leading pulse oximetry
systems.
"During Dräger’s long history, we have made one commitment to
our customers, and that is to provide them with the best technology possible,"
stated Frank Rochlitzer, President of Dräger Medizintechnik GmbH. "We spent
considerable time evaluating the performance of Masimo SET pulse oximetry and
concluded that Masimo SET pulse oximetry would be an ideal choice for our future
monitors and our customers."
Joe E. Kiani, President and Chief Executive
Officer of Masimo Corporation, stated, "Dräger is widely recognized as one of
the premier providers of medical equipment in the world. Just about everything
they sell is considered best in its class and most people in the industry
recognize Dräger as being synonymous with quality. After working with Dräger, I
now understand how they achieved such a reputation. Their team is as solid a
group of professionals that we have had the pleasure to work with. We are
delighted to have Dräger as a partner." |
